The Dendreon Alumni: Where Are They Now?

Andy Scherer, president, Scherer & Associates

Kathleen Schneider, research associate III, CMC Icos Biologics

Deborah Siegel, research scientist, genome sciences, University of Washington School of Medicine

Martin Simonetti, CEO, VLST

Paul Slagle, senior research associate, Allozyne

Julie Ann Slyfield, IT, senior security analyst, Mutual of Enumclaw

Gary Smith, process development engineer, ALK-Abello

Bouwien Smits-Sana, associate director, quality assurance, Gilead Sciences

Linda Staley, retired

Hartmut Stecher, senior director, head of medical affairs, Seattle Genetics

George Strang, manager, clinical data management, Genentech

Ryan Thurston, senior associate, Amgen

Carrie Trujillo, scientific project coordinator II, scientific development, HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center [Added: 8:50 pm, 4/1/10]

Frank Valone, chief medical officer, Fibrogen

Peter Van Vlasselaer, CEO, Arresto Biosciences

Suleman Verjee, founder and CEO, Versante International

Joanna Ward, senior director, Seattle Genetics

Jami Wollan, clinical immunology group leader

Sue Woyshnis, independent IT and services professional

Susan Wyrick, controller, Trubion Pharmaceuticals

Pages: Page 1, Page 2, Page 3, Page 4

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.